brand-logo
Subscribe

Zinzino Acquires Sanki

by

Zinzino has signed an agreement with Mexico-based direct sales company Sanki to acquire the rights to the company’s distributor database and associated customer register, inventory, and IP rights. In addition to the assets, 100% of the shares in Sanki’s subsidiaries in Colombia and Peru are being acquired to accelerate the establishment processes and increase distribution power in those countries.

The acquisition of Sanki adds increased distribution power in combination with an innovative, trademarked product portfolio, tailored to be integrated into Zinzino’s test-based product concept. The asset acquisition is also another strategically important step in Zinzino’s growth plans, with a focus on improving personal health and well-being on a global level with innovative biotechnology and a groundbreaking product portfolio marketed through direct sales.

Sanki is a direct sales company in the health segment, operating in North America (USA and Mexico) and South America (Colombia and Peru). Its brand portfolio offers a range of innovative and patented products in the field of health and well-being. The business has a total annual turnover of approximately USD 12 million. The collaboration with Zinzino is expected to add growth through the synergies that arise in the joint networks, combined with the integration of Sanki’s product portfolio into Zinzino’s test-based product concept.

Following the acquisitions of VMA Life in 2020, Enhanzz in 2022, Xellissand ACN in 2024, and the asset acquisitions of Zurvita, Valentus, Ecosystem, Truvy, and Bode Pro in 2025, Zinzino has been looking for further investments to maintain its sustainable, profitable growth, strengthen its distribution power, expand into new markets, and leverage its product portfolio in new consumer areas.

“Individual advice and tailor-made solutions are the future, and not just in health and wellness,” say Dag Bergheim Pettersen, CEO of Zinzino. Together with Alejandro Lopez Tello, CEO and co-founder of Sanki, we have many years of combined industry experience. We are delighted to have taken the next step and are now well equipped to drive the modern, personalized shopping experience forward through direct sales.

Nature’s Sunshine Reports Q3 2025 Financial Results

by

Nature’s Sunshine announced its financial results for the third quarter of 2025. Net sales improved by 12% year-over-year, reaching $128.3 million. Gross profit margin improved slightly from 71.3% in the third quarter of 2024 to 73.3%. Adjusted EBITDA was $15.2 million, compared to $10.7 million in Q3 2025.

“The momentum in our business continued to accelerate in the third quarter, with record net sales of $128 million and adjusted EBITDA of $15 million, representing year-over-year growth of 12% and 42%, respectively,” said Shane Jones, Nature’s Sunshine CFO. “Our strategic investments in North America Digital continue to pay off, as a surge in new customers, coupled with strong retention, yielded a 52% year-over-year increase in Digital sales. We also continue to see exceptional results in Asia-Pacific, driven by 30%+ growth in both Japan and China during the quarter.”

Operating income in the third quarter grew to $9 million compared to $5.3 million in the year-ago quarter. Other income, net, in the third quarter was $0.7 million, down from $2.6 million in the same period last year, primarily due to foreign exchange gains in Asia and Europe but offset by foreign exchange losses in Latin America and North America.

“Finally, we also saw strong benefit from our cost saving initiatives as gross margin increased 200 basis points to 73.3% during the quarter, its highest level in 15 quarters,” Jones said. “We’re very pleased with the progress we’re making across the business and remain confident in our ability to deliver sustainable profitability and create long-term value for shareholders. I am excited to be working alongside our new CEO, Ken Romanzi, who brings the right experience to take this brand to the next level.”

The company now expects net sales for full-year 2025 to be between $476 million to $480 million with an adjusted EBITDA between $47 million to $49 million. The company ended the quarter with cash and cash equivalents of $95.6 million and no debt.

Nu Skin Reports Q3 2025 Financial Results

by

Nu Skin Enterprises Inc. announced its financial results for the third quarter of 2025. Revenue during the quarter was $364.2 million, down from $430.1 million in the third quarter of 2024. While this total represents a 15.3% decline (11.5% when excluding 2024 Mavely revenue), the results were in line with earlier guidance. Gross margin during the quarter remained relatively stable at 70.5%, compared to 70.1% in the same period of 2024, which the company attributes to operational discipline and further expansion of its net cash position.

“We are pleased with our third quarter results, which were in line with expectations, as we continue to navigate a challenging macro environment while preparing for the introduction of our intelligent wellness platform,” said Ryan Napierski, Nu Skin President and CEO. “Our Latin America region once again delivered strong, double-digit year-over-year growth, and we’re encouraged by positive trends such as sequential growth in several of our reporting segments. Through disciplined execution and operational efficiency, we delivered earnings per share at the high end of our guidance range.”

Fourth quarter guidance now includes revenue between $365 million to $400 million, with full-year 2025 revenue expected between $1.48 billion to $1.51 billion.

“As we look ahead, there is growing excitement and energy for the upcoming launch of our Prysm iO intelligent wellness platform and our expansion into India – two pivotal milestones that will accelerate our vision to become the world’s leading intelligent beauty and wellness company,” Napierski said. “Our leaders are eager to begin building with Prysm iO with a limited sales leader preview in late Q4 followed by broader sales leader availability and a full consumer launch in 2026. We believe our AI-powered wellness assessment platform will stimulate growth in our nutritional supplements business by providing personalized product recommendations and subscriptions to drive customer lifetime value. We are also preparing for pre-market opening activities in India this month as we build sales momentum ahead of a formal launch in the second half of 2026. We believe these initiatives will lead to a renewed era of growth and shareholder value for Nu Skin.”

eXp World Holdings Reports Q3 2025 Financial Results

by

eXp World Holdings, the holding company for eXp Realty, announced its financial results for the third quarter of 2025. Revenue during the period grew 7% to $1.3 billion, as compared to the third quarter of 2024. Third quarter net income was $3.5 million, or $0.02 per diluted share. Adjusted third quarter EBITDA was $17.7 million, while net cash provided by operating activities reached $28.9 million.

“Our third quarter results underscore the strength of eXp’s model and the power of our agents,” said Leo Pareja, eXp Realty CEO. “Continued momentum in agent growth, productivity and retention are driving higher revenue, profitability and overall performance. Our agent-first culture, combined with ongoing innovation across the eXp platform, continues to attract and empower top agents and teams around the world. As we scale, our focus remains on delivering even greater value to our agents — because when they thrive, eXp thrives.”

Real estate transactions during the quarter increased 3% year-over-year to 12,516, and real estate sales volume increased 7% to $54.1 billion. The number of agents and brokers on the eXp Realty platform fell slightly (2%) to 83,446.

“eXp continues to solidify its position as the platform for the future of real estate,” said Glenn Sanford, eXp World Holdings Founder, Chairman and CEO. “Now more than ever, eXp is the place for agents to be as the industry evolves globally and agents seek a platform that provides not just flexibility, but the resources to thrive — from SUCCESS coaching and elite training programs to mentorship, community, and a compelling value stack that supports both business and personal growth. Our third quarter results are a reflection of eXp’s continued focus on innovation and our ability to leverage technology, with a focus on AI, to enhance speed, agility and differentiation in a rapidly changing real estate landscape.”

The company ended the quarter with cash and cash equivalents of $112.8 million.

Coway Reports Q3 2025 Financial Results

by

Coway Co., Ltd. announced its financial results for the third quarter of 2025. Revenue during the period increased 14% year-over-year to $859 million. Operating profit during the quarter also increased by 17.4% year-over-year to $166 million. Year-to-date revenue improved 15.8% over the same period of 2024, reaching $2.5 billion.

The company’s strong domestic performance, which saw a 12% year-over-year increase, was driven by what the company called “robust sales” of the new Icon Ice Water Purifier series. Overall, sales of Coway’s ice water purifiers rose 25% year-over-year between August and September, a new sales record for the category.

Sales among Coway’s overseas subsidiaries grew 19.9% year-over-year, with Malaysia reporting a 20% increase. The US and Thailand also posted strong revenue numbers, reporting 7.8% and 28.5% growth respectively.

“Strong sales of our leading home environment appliances, along with the steady growth of our BEREX lineup of beds and massage chairs, have driven overall performance this quarter,” said Soon Tae Kim, Coway Chief Financial Officer. “Building on this core business competitiveness, we will continue to strengthen our future growth drivers and sustain balanced momentum across both domestic and global markets going forward.”

USANA Helps Utah Families Impacted by SNAP Funding Cuts

by

USANA, through its philanthropic organization the USANA Foundation, is working to alleviate the growing food insecurity in Utah as a result of the ongoing government shutdown and SNAP funding cuts. This week, USANA gathered community partners and volunteers to assemble 3,000 bags of food for children and families affected by the SNAP cutbacks.

The philanthropic event was held at the USANA Foundation Headquarters where volunteers from local organizations, including Bountiful Food Pantry, For the Kids, the Utah Department of Cultural and Community Engagement and Kristen Andrus’ Gather for Impact, formed assembly lines to pack food and nutrition for these in-need students and families. Five Salt Lake City area school districts, as well as two nonprofits and food pantries will distribute the 3,000 bags of food.

“This event demonstrated the incredible impact that collaboration can have,” said Brian Paul, USANA Foundation President. “When organizations and individuals come together to support families in crisis, we strengthen our entire community. One in six kids in Utah are at risk of going hungry, and being able to help feed these families is what the USANA Foundation is all about.”

Natural Health Trends Reports Q3 2025 Financial Results

by

Natural Health Trends Corp. announced its financial results for the third quarter of 2025. Revenue during the quarter fell 11% to $9.5 million, compared to $10.7 million in the same quarter of 2024, which the company attributes in part to the timing of a product promotion and presale of a new skincare line in Hong Kong. Operating loss during the quarter was $495,000, compared to $275,000 in the same period last year.

The company posted a net loss for the quarter of $431,000, or $0.04 per diluted share, compared to a net income of $35,000 in Q3 2024. Active Member numbers declined from 30,870 at the end of 2024 to 28,030 at the end of the third quarter 2025.

Year-to-date revenue fell 7% year-over-year to $30 million with an operating loss of $1.2 million

“The economic outlook in our largest market remains challenging in the near term,” said Chris Sharng, Natural Health Trends Corp. President. “We are undertaking a major restructuring, which we expect will result in $1.5 million annualized savings. Our ongoing measures include optimizing our workforce and relocating product manufacturing to Asia. As part of these restructuring initiatives, we expect to incur a one-time charge of approximately $250,000 in the fourth quarter and anticipate a reduction in our quarterly cash dividend to $0.10 per share beginning in the first quarter next year. These actions will enable investments in new systems and technologies, including an AI-enabled marketing app and a member-interface business suite, as well as new marketing initiatives designed to drive member growth and engagement. By aligning costs with global sales performance, we are positioning the company for sustainable growth, profitability, and long-term value creation.”

The company ended the quarter with cash, cash equivalent and marketable securities of $32 million, down from $43.9 million at the end of 2024.

Sunrider Serum Wins 2025 Beauty Innovation Award

by

Sunrider’s Dr. Chen UrbanShield Nourishing Serum was named Hydration Serum of the Year at the 2025 Beauty Innovation Awards. This event celebrates groundbreaking products, companies and services in the global beauty industry that exemplify the advancement of beauty through creativity, efficacy and conscious innovation. Entrants are judged based on innovation, performance, functionality, aesthetics, impact and standard of excellence.

The UrbanShield Nourishing Serum was selected for its plant-powered formula, hydration properties and defense against environmental stressors like pollution and sunlight. Created with the guidance of Sunrider’s founder Dr. Tei-Fu Chen, the serum includes probiotics, peptides and antioxidants and is designed to support the skin barrier, visibly diminish fine lines, improve elasticity and minimize pores and redness.

“Dr. Chen UrbanShield Nourishing Serum embodies Sunrider’s commitment to innovation, beauty, and wellness,” said Sunny Beutler, Sunrider CEO. “We are thrilled to be recognized by the Beauty Innovation Awards for a formula that not only hydrates and protects the skin’s appearance but also empowers our customers to face each day with confidence.”

Herbalife Reports Q3 2025 Financial Results

by

Herbalife Ltd. announced its financial results for the third quarter of 2025. Net sales during the quarter reached $1.3 billion, a 2.7% year-over-year increase. North America saw a 1% year-over-year improvement in net sales, posting its first quarterly gain since the second quarter of 2021. Gross profit margin was 77.7%, a slight decline from 78.3% in the third quarter of 2024. Adjusted EBITDA was $163 million.

Four of the company’s five regions reported year-over-year growth in its new distributor numbers, with North America showing the strongest recruitment increase at 17%. The Diamond Development Mastermind Program, a training and accountability program, recently expanded to India and has been a critical part of supporting this momentum.

“Herbalife’s third-quarter performance reflects continued progress in our transformation strategy, as well as disciplined financial and operational execution,” said Stephan Gratziani, Herbalife CEO. “With North America returning to growth and adjusted EBITDA exceeding guidance, we are delivering on our commitments and building forward momentum.”

The company paid $2 million during the quarter as part of its asset acquisition agreement for Pro2col Health LLC and beta release of the Pro2col technology platform. Expanded access to the beta version of the Pro2col app rolled out in late October and introduced enhanced and expanded features within the Pro2col digital experience that are expected to support distributor activities and daily operations. Pro2col Beta 2.0 is now scheduled to be released to all customers and distributors in the US and Puerto Rico by the end of 2025 and additional global markets in 2026.

“Across our business, product innovation, digital evolution and disciplined execution are driving momentum and delivering results,” Gratziani said. “Through our transformation, we are equipping and supporting our distributors to grow stronger businesses—supporting progress today and building a clear path to sustainable growth and long-term shareholder value.”

Fourth quarter 2025 guidance now includes net sales increases between 1.5% and 5.5% year-over-year with full-year 2025 net sales expected to reflect a 0.3% to 0.7% year-over-year improvement.

Zinzino Releases Preliminary Sales Report for October 2025

by

Zinzino reported its preliminary October 2025 revenue. Compared to October 2024, overall revenue for the company increased 65%, totaling $34 million. Accumulated revenue for year-to-date 2025 improved 55% to $274 million.

Faun Pharma’s external sales did see a 51% decrease in revenue, which offset major gains in certain regions where growth was significant. Central Europe, which includes Austria, Germany and Switzerland, saw a 69% increase in year-to-date revenue. North America, which includes Canada, the US and Mexico, and Asia-Pacific, which includes Australia, New Zealand, Hong Kong, India, Malaysia, Singapore, Taiwan, Thailand, China and the Philippines, reported increases of 183% and 353% respectively.

Oriflame Agrees to Comprehensive Recapitalization Transaction, Releases Financial Report for Q3 2025

by

Oriflame announced its financial statement for the third quarter of 2025. The company recently concluded an agreement with its creditors and shareholders for a recapitalization of its capital structure and an extension of its revolving credit facility to June 2029, as well as a significant de-levering of its balance sheet. The company expects these terms to significantly strengthen its financial position and support its ongoing operational turnaround. This agreement builds on the $57 million investment secured from a consortium of long-term European investors, which was announced in March 2025.

The recapitalization transaction will now support Oriflame’s significant operational transformation, which the company states is “already delivering improvements to key performance metrics, driving a return to growth in sales and recruitment in over 20 markets.”

“The successful completion of this transaction marks an exciting new chapter for us all at Oriflame, one with a strong, de-levered balance sheet and continued support from investors,” said Anna Malmhake, Oriflame CEO. “This milestone positively positions the business for future success, allowing us to focus on driving forward our transformation plan, accelerating innovation and continuing to provide a market-leading service to our customers and stakeholders. I look forward to continuing our work as we solidify the business’s position and set it up for long-term growth and future success.”

During the third quarter of 2025, the company’s Euro sales declined 4% to $144 million with an adjusted EBITDA of $5.7 million. Adjusted net profit was reported as a loss of $23.3 million, with adjusted cash flow from operating activities at -$10.9 million. Year-to-date 2025 Euro sales fell 7% to $464.5 million, with an adjusted EBITDA of $0.46 million.

The company’s Beauty Community Model (BCM), implemented in 48 markets, represented more than 80% of sales and will be a high priority as the program is implemented in remaining markets, with expectations to finalize by the beginning of 2026.

“Although the company is facing uncertainties as to its ability to continue as a going concern due to the company’s challenging results during the past couple of years and liquidity, management believes that such uncertainties will be addressed by the recapitalization and by the measures taken to drive positive business performance,” the company wrote in a statement.

The company ended the quarter with a cash balance of $38 million, down from $57.3 million at the start of the quarter.

Xyngular Launches XMD Wellness

by

Xyngular debuted XMD Wellness, a new telehealth platform that connects consumers with licensed providers and access to personalized care. Through XMD Wellness, consumers will receive guided peptide therapy paired with clinical expertise, supplements and everyday lifestyle tools.

Xyngular’s companion products, Clear Protein+, Trimstix and Complete Probiotic, have been designed to support gut health, energy and muscle preservation throughout a customer’s metabolic journey.

“Only 12% of Americans are metabolically healthy,” said Chanelle Cozette Jepson, Xyngular Senior Vice President of Product Development and Marketing. “That means nearly nine out of ten people are struggling—not always from lack of effort, but from lack of access. XMD Wellness was built to change that by making real, science-based healthcare available to everyone.”

Xyngular has partnered with one of the nation’s largest telehealth networks, which includes more than 20,000 licensed clinicians and 503-A certified pharmacies to enable patients to receive personalized peptide prescriptions, ongoing provider support and supplement stacks for gut, energy and hormone balance.

“This launch marks the next evolution of wellness,” said Oliver Dibblee, Xyngular President. “We’re bridging the gap between medical precision and real-life accessibility, making advanced health solutions practical for everyday people.”